483
George Timothy Kelly. M.D.FDA 483 - George Timothy Kelly. M.D. - February 15, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of G. Timothy Kelly, M.D. in Las Vegas, NV, revealed significant deviations from study protocols and inadequate record-keeping for investigational products. Observations included failures in conducting required subject analyses and assessments, issues with eligibility determination, and poor investigational drug accountability. These findings indicate a lack of adherence to clinical investigation standards.
Open in Dashboard
ID · 7f6c2d20-73f0-42be-a376-00c3fd43062c